Literature DB >> 21590625

Posterior reversible encephalopathy syndrome: a review.

Steven K Feske1.   

Abstract

Encephalopathy due to reversible cerebral edema is an important cause of neurologic morbidity accompanying many disorders. Although controversy remains concerning the pathophysiologic trigger, the mechanism of this disorder ultimately depends on failure of the blood-brain barrier to maintain the compartmentalization of intravascular fluid. This failure of the blood-brain barrier depends primarily on the capillary hydrostatic pressure, under the influence of the systemic blood pressure, and on the integrity of the structures that make up the blood-brain barrier, most importantly the vascular endothelium, under the influence of various diseases and toxic medications. Although typical clinical contexts and presentations have been well defined, many patients have atypical features that pose a diagnostic challenge. Therefore, awareness of this clinical variability is important for prompt diagnosis. This review discusses the history and pathophysiology of posterior reversible encephalopathy syndrome and then addresses its clinical diagnosis and management. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21590625     DOI: 10.1055/s-0031-1277990

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  55 in total

1.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer.

Authors:  Christina A K Kim; Julie Price-Hiller; Quincy S Chu; Keith Tankel; Ron Hennig; Michael B Sawyer; Jennifer L Spratlin
Journal:  Invest New Drugs       Date:  2014-05-23       Impact factor: 3.850

3.  Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients.

Authors:  Tom K Gallagher; Kathryn A Thomas; Daniela P Ladner; Daniel Ganger; Farzaneh A Sorond; Shyam Prabhakaran; Michael M Abecassis; Jonathan P Fryer; Eric M Liotta
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.

Authors:  Masafumi Tenta; Haruhito Adam Uchida; Tomokazu Nunoue; Ryoko Umebayashi; Yuka Okuyama; Masashi Kitagawa; Yohei Maeshima; Hitoshi Sugiyama; Jun Wada
Journal:  CEN Case Rep       Date:  2014-12-30

5.  Acute chorea in posterior reversible encephalopathy syndrome.

Authors:  Jeong-Jin Park; Jong-Hyeon Ahn; Choong-Kun Ha; Eun-Kee Bae
Journal:  J Neurol       Date:  2012-10-18       Impact factor: 4.849

Review 6.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

7.  Posterior reversible encephalopathy syndrome postautologous peripheral stem cell transplantation for multiple myeloma.

Authors:  Shahriar Raj Zaman
Journal:  BMJ Case Rep       Date:  2012-07-19

Review 8.  Posterior reversible encephalopathy syndrome in a child with steroid-resistant nephrotic syndrome: a case report and review of literature.

Authors:  Yu Zhang; Jianhua Zhou; Yu Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

9.  Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.

Authors:  J Merayo-Chalico; A Barrera-Vargas; G Juárez-Vega; J Alcocer-Varela; A Arauz; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2018-01-16       Impact factor: 4.330

10.  White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.

Authors:  Young Noh; Sang Won Seo; Seun Jeon; Jong Min Lee; Jung-Hyun Kim; Geon Ha Kim; Hanna Cho; Cindy W Yoon; Hee Jin Kim; Byoung Seok Ye; Sung Tae Kim; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Michael Ewers; Michael W Weiner; Jae-Hong Lee; David J Werring; Dae Ryong Kang; Chang Soo Kim; Duk L Na
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.